Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  LMB-2 immunotoxin
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
LMB-2 Immunotoxin in Treating Patients with Hairy Cell Leukemia
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 06-C-0150, NCI-2009-00231, CDR0000482415, NCT00337311, P6760, 7834, NCI-06-C-0150, NCI-P6760, NCI-7834, NCT00321555
Start Over